A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Conditions
Solid Tumours · Sarcoma · HNSCC · Non Small Cell Lung Cancer · NSCLC · Colorectal Cancer (CRC) · Myxofibrosarcoma (MFS) · Solitary Fibrous Tumors · Dedifferentiated Liposarcoma · Undifferentiated Pleomorphic Sarcoma (UPS) · Leiomyosarcoma · Leiomyosarcoma (LMS) · Gastric Cancer (GC) · Gastric Cancer Adenocarcinoma Metastatic · Gastric / Gastroesophageal Junction Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Precision NextGen Oncology and Research Center, Beverly Hills, California, United States
Sarcoma Oncology Center, Santa Monica, California, United States
MD Anderson Cancer Center, Houston, Texas, United States
Chris O'Brien Lifehouse, Sydney, New South Wales, Australia
Linear Clinical Research, Perth, Western Australia, Australia
The Beatson, Glasgow, United Kingdom
Leicester Royal Infirmary, Leicester, United Kingdom
University College London Hospital, London, United Kingdom
The Christie, Manchester, United Kingdom
Churchill Hospital, Oxford, United Kingdom